Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2019820938
Up to date per 04.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2019820938
Title / Product Name
VERBESSERTE SYNTHESE EINES WICHTIGEN ZWISCHENPRODUKTES EINER KRAS-G12C-INHIBITORVERBINDUNG
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2019820938
EP Publication Number
3880670
E-Number
1574720
Language
EN
PCT Number
US19061815
Publication Date
22.09.2021 A
07.06.2023 B1
Registration Date
07.06.2023
AT Publication Date
15.06.2023
Application Date
15.11.2019
Registration Number
-
Priorities
16.11.2018
US
201862768802 P
IPC
C07D 401/04 20060101AFI20200522BHEP
Maximum Duration of Protection
15.11.2039
Owner
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, California 91320
US
Representative
Representative
Häupl & Ellmeyer KG, Patentanwaltskanzlei
Mariahilfer Straße 50 (Kirchengasse 1)
1070 Wien
AT
Inventor
PARSONS, Andrew Thomas
One Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A
Thousand Oaks, California 91320-1799
US
COCHRAN, Brian McNeil
One Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A
Thousand Oaks, California 91320-1799
US
POWAZINIK, IV, William
One Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A
Thousand Oaks, California 91320-1799
US
CAPORINI, Marc Anthony
One Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A
Thousand Oaks, California 91320-1799
US
Information about Fees
Click here to load the fees